WGB Stock Chart & Stats
€106.00
€3.00(3.61%)
At close: 4:00 PM EDT
€106.00
€3.00(3.61%)
Day’s Range― - ―
52-Week Range€54.00 - €108.00
Previous CloseN/A
Volume0.00
Average Volume (3M)9.00
Market Cap
€3.66B
Enterprise Value€4.59K
Total Cash (Recent Filing)€21.38M
Total Debt (Recent Filing)€1.36B
Price to Earnings (P/E)34.0
Beta0.34
Next Earnings
Oct 22, 2026EPS Estimate
1.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.69
Shares Outstanding33,992,046
10 Day Avg. Volume0
30 Day Avg. Volume9
Financial Highlights & Ratios
PEG Ratio-1.49
Price to Book (P/B)1.56
Price to Sales (P/S)1.48
P/FCF Ratio25.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€101.67Price Target Upside-4.08% Downside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)5.3
Revenue Forecast (FY)€1.57B
Bulls Say, Bears Say
Bulls Say
Diversification And Market ExposureA diversified business model and participation in emerging cardiovascular markets such as PFA and RDN position the company to capture growth from product innovation and favorable demographics.
M&A PotentialA potential sale or strategic transaction could attract bidders at premiums above current trading levels, offering a clearer path to shareholder value realization.
ValuationCurrent valuation underappreciates Integer's assets, creating upside if market recognition or asset re-pricing occurs.
Bears Say
Analyst Sentiment And Guidance UncertaintyRecent analyst downgrades and reduced growth expectations reflect diminished confidence and can weigh on the stock while consistent financial improvement is not yet demonstrated.
Customer Concentration RiskHigh reliance on a small number of customers concentrates revenue risk and links company results closely to a few partners' product performance.
Product Demand HeadwindsReduced demand for three key products is constraining revenue growth and pressuring near-term profitability until volumes recover.
Integer Holdings News
WGB FAQ
What was Integer Holdings Corporation’s price range in the past 12 months?
Integer Holdings Corporation lowest stock price was €54.00 and its highest was €108.00 in the past 12 months.
What is Integer Holdings Corporation’s market cap?
Integer Holdings Corporation’s market cap is €3.66B.
When is Integer Holdings Corporation’s upcoming earnings report date?
Integer Holdings Corporation’s upcoming earnings report date is Oct 22, 2026 which is in 48 days.
How were Integer Holdings Corporation’s earnings last quarter?
Integer Holdings Corporation released its earnings results on Aug 03, 2026. The company reported €1.376 earnings per share for the quarter, beating the consensus estimate of €1.186 by €0.19.
Is Integer Holdings Corporation overvalued?
According to Wall Street analysts Integer Holdings Corporation’s price is currently Overvalued.
Does Integer Holdings Corporation pay dividends?
Integer Holdings Corporation does not currently pay dividends.
What is Integer Holdings Corporation’s EPS estimate?
Integer Holdings Corporation’s EPS estimate is 1.45.
How many shares outstanding does Integer Holdings Corporation have?
Integer Holdings Corporation has 33,992,046 shares outstanding.
What happened to Integer Holdings Corporation’s price movement after its last earnings report?
Integer Holdings Corporation reported an EPS of €1.376 in its last earnings report, beating expectations of €1.186. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Integer Holdings Corporation?
Currently, no hedge funds are holding shares in DE:WGB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Integer Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€101.67 (-4.08% Downside)
€101.67 (-4.08% Downside)
Blogger Sentiment
Bullish
DE:WGB Sentiment 75%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Integer Holdings Corporation
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
WGB Company Deck
WGB Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mixed picture: a modest top-line improvement in Q1 (reported +0.5%, organic +1.3%) and several strategic positives (share buybacks, lower interest expense, targeted cost actions, pipeline strength and a Board-initiated strategic review) were offset by meaningful near-term profitability pressures (adjusted operating income down 14%, margin contraction of 230 bps), weaker cash flow in Q1, and a downward revision to full-year 2026 revenue and profit guidance. Management characterizes the demand softness—primarily in electrophysiology—as temporary normalization and emphasized actions to protect long-term growth, but the guidance cuts and margin contraction represent notable near-term headwinds.View all DE:WGB earnings summariesWGB Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€101.67
▼(-4.08% Downside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Alphatec Holdings
―
Glaukos
―
LivaNova
―
Inspire Medical Systems
―
TransMedics Group
―











